Scarica l'app Stockscreener
15.19
0.85%
-0.13
Dopo l'orario di chiusura:
15.19
Precedente Chiudi:
$15.32
Aprire:
$15.46
Volume 24 ore:
390.31K
Relative Volume:
2.14
Capitalizzazione di mercato:
$666.09M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+9.52%
1M Prestazione:
+1.95%
6M Prestazione:
+37.59%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$14.86
$16.40
Intervallo di 1 settimana:
$13.78
$16.40
Portata 52W:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
Nome
Maze Therapeutics Inc
Settore
Industria
Telefono
(650) 850-5070
Indirizzo
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Confronta MAZE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
15.19 | 671.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-08 | Iniziato | Wedbush | Outperform |
Maze Therapeutics Inc Borsa (MAZE) Ultime notizie
Is Maze Therapeutics Inc. showing signs of accumulationQuarterly Portfolio Review & Verified Momentum Watchlists - Newser
Sentiment analysis tools applied to Maze Therapeutics Inc.New Guidance & Free Safe Entry Trade Signal Reports - Newser
Understanding Maze Therapeutics Inc.’s price movementOptions Play & Daily Profit Focused Stock Screening - Newser
What MACD and RSI say about Maze Therapeutics Inc.2025 Valuation Update & Real-Time Stock Movement Alerts - Newser
What indicators show strength in Maze Therapeutics Inc.July 2025 Setups & AI Enhanced Trading Signals - Newser
Statistical indicators supporting Maze Therapeutics Inc.’s strengthBreakout Watch & Weekly High Return Stock Forecasts - Newser
Using data models to predict Maze Therapeutics Inc. stock movementJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Custom strategy builders for tracking Maze Therapeutics Inc.July 2025 Movers & Safe Capital Investment Plans - Newser
Maze Therapeutics Inc. stock volume spike explained2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Risk vs reward if holding onto Maze Therapeutics Inc.July 2025 Opening Moves & Safe Entry Point Alerts - Newser
Multi asset correlation models including Maze Therapeutics Inc.Risk Management & Weekly Chart Analysis and Guides - Newser
Maze Therapeutics’ Claims For Unapproved Kidney Disease Drug Face Regulatory Scrutiny - insights.citeline.com
Should value investors consider Maze Therapeutics Inc.July 2025 Levels & Growth Focused Stock Reports - khodrobank.com
Is it too late to sell Maze Therapeutics Inc.Market Growth Report & Breakout Confirmation Trade Signals - Newser
Visual analytics tools that track Maze Therapeutics Inc. performanceProduct Launch & Free Reliable Trade Execution Plans - Newser
Maze Therapeutics initiated with a Buy at BTIG - TipRanks
BTIG initiates coverage on Maze Therapeutics with a Buy rating and PT of $30. - AInvest
Maze Therapeutics appoints Tahir as Chief Financial Officer - TipRanks
Maze Therapeutics appoints Misbah Tahir as chief financial officer - Investing.com
Maze Therapeutics Appoints Misbah Tahir as CFO - TipRanks
Maze Therapeutics Appoints Misbah Tahir as New CFO - AInvest
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer - GlobeNewswire
Former IGM Biosciences CFO Who Raised $1B Joins Maze Therapeutics Ahead of Major Clinical Milestones - Stock Titan
BTIG Initiates Maze Therapeutics at Buy With $30 Price Target - MarketScreener
Is Maze Therapeutics Inc. stock showing strong momentum2025 Institutional Moves & Technical Pattern Recognition Alerts - khodrobank.com
How to monitor Maze Therapeutics Inc. with trend dashboardsWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
Can Maze Therapeutics Inc. outperform in the next rallyLayoff News & Community Verified Trade Signals - khodrobank.com
Will Maze Therapeutics Inc. stock recover after earningsWeekly Investment Recap & AI Driven Stock Movement Reports - khodrobank.com
Maze Therapeutics Inc. Breakout Confirmed by Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
Institutional scanner results for Maze Therapeutics Inc.2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Historical volatility pattern of Maze Therapeutics Inc. visualizedTrade Signal Summary & Real-Time Volume Triggers - Newser
Can trapped investors hope for a rebound in Maze Therapeutics Inc.2025 Earnings Impact & Daily Volume Surge Trade Alerts - Newser
Maze Therapeutics Inc. Approaches Psychological Resistance Level getLinesFromResByArray error: size == 0 - newsyoung.net
When is the best time to exit Maze Therapeutics Inc.Gold Moves & AI Forecast for Swing Trade Picks - Newser
Maze Therapeutics Inc Azioni (MAZE) Dati Finanziari
Non sono disponibili dati finanziari per Maze Therapeutics Inc (MAZE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):